Bridgeway Capital Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $386K | Buy |
5,600
+600
| +12% | +$39.9K | 0.01% | 912 |
|
|
2026
Q1 | $310K | Hold |
5,000
| – | – | 0.01% | 924 |
|
|
2025
Q4 | $280K | Hold |
5,000
| – | – | 0.01% | 951 |
|
|
2025
Q3 | $315K | Hold |
5,000
| – | – | 0.01% | 913 |
|
|
2025
Q2 | $285K | Hold |
5,000
| – | – | 0.01% | 877 |
|
|
2025
Q1 | $280K | Buy |
+5,000
| New | +$300K | 0.01% | 851 |
|
|
2020
Q2 | – | Sell |
-4,900
| Closed | -$461K | – | 1402 |
|
|
2020
Q1 | $461K | Sell |
4,900
-5,000
| -51% | -$465K | 0.01% | 800 |
|
|
2019
Q4 | $1.07M | Sell |
9,900
-4,000
| -29% | -$405K | 0.01% | 720 |
|
|
2019
Q3 | $1.33M | Hold |
13,900
| – | – | 0.02% | 645 |
|
|
2019
Q2 | $1.33M | Hold |
13,900
| – | – | 0.02% | 649 |
|
|
2019
Q1 | $1.23M | Sell |
13,900
-3,000
| -18% | -$264K | 0.02% | 685 |
|
|
2018
Q4 | $1.4M | Sell |
16,900
-3,000
| -15% | -$264K | 0.02% | 617 |
|
|
2018
Q3 | $1.88M | Sell |
19,900
-2,600
| -12% | -$248K | 0.02% | 658 |
|
|
2018
Q2 | $2.48M | Hold |
22,500
| – | – | 0.03% | 552 |
|
|
2018
Q1 | $2.22M | Sell |
22,500
-3,050
| -12% | -$272K | 0.02% | 551 |
|
|
2017
Q4 | $2.08M | Sell |
25,550
-2,450
| -9% | -$191K | 0.02% | 589 |
|
|
2017
Q3 | $2.06M | Sell |
28,000
-6,000
| -18% | -$432K | 0.02% | 589 |
|
|
2017
Q2 | $2.46M | Buy |
34,000
+100
| +0.3% | +$6.58K | 0.03% | 512 |
|
|
2017
Q1 | $2.11M | Hold |
33,900
| – | – | 0.03% | 555 |
|
|
2016
Q4 | $2.47M | Sell |
33,900
-2,000
| -6% | -$130K | 0.03% | 500 |
|
|
2016
Q3 | $2.15M | Sell |
35,900
-50
| -0.1% | -$3.18K | 0.03% | 510 |
|
|
2016
Q2 | $2.27M | Buy |
35,950
+50
| +0.1% | +$3.23K | 0.04% | 472 |
|
|
2016
Q1 | $2.25M | Sell |
35,900
-400
| -1% | -$23.6K | 0.04% | 476 |
|
|
2015
Q4 | $2.13M | Hold |
36,300
| – | – | 0.04% | 480 |
|
|
2015
Q3 | $1.96M | Hold |
36,300
| – | – | 0.04% | 494 |
|
|
2015
Q2 | $2.17M | Hold |
36,300
| – | – | 0.04% | 484 |
|
|
2015
Q1 | $2.17M | Hold |
36,300
| – | – | 0.04% | 495 |
|
|
2014
Q4 | $2.18M | Hold |
36,300
| – | – | 0.05% | 487 |
|
|
2014
Q3 | $1.77M | Hold |
36,300
| – | – | 0.04% | 531 |
|
|
2014
Q2 | $1.87M | Hold |
36,300
| – | – | 0.05% | 531 |
|
|
2014
Q1 | $2.1M | Hold |
36,300
| – | – | 0.06% | 478 |
|
|
2013
Q4 | $2.08M | Sell |
36,300
-50
| -0.1% | -$2.74K | 0.06% | 461 |
|
|
2013
Q3 | $2.16M | Buy |
36,350
+50
| +0.1% | +$2.73K | 0.07% | 390 |
|
|
2013
Q2 | $1.97M | Buy |
+36,300
| New | +$1.71M | 0.08% | 341 |
|
Other funds holding UTMD
BIP
MA
RHJA
Bridgeway Capital Management's UTMD Position: Q2 2026 in Review
Bridgeway Capital Management increased its Utah Medical Products (UTMD) stake by 12% in Q2 2026, buying an estimated $39.9K and bringing the position to 5,600 shares worth $386K. The position accounts for 0.01% of the portfolio, ranked #912.
Bridgeway Capital Management first reported a position in UTMD in Q2 2013 and has held it in 34 quarters since. The position peaked at $2.48M in Q2 2018. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.
- Bridgeway Capital Management held 5,600 shares of Utah Medical Products worth $386K as of Q2 2026.
- Bridgeway Capital Management bought 600 Utah Medical Products shares in Q2 2026, an estimated $39.9K.
- Utah Medical Products made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #912 holding.
- Bridgeway Capital Management first reported a position in Utah Medical Products in Q2 2013 and has held it in 34 quarters since.
- Bridgeway Capital Management's Utah Medical Products position peaked at $2.48M in Q2 2018.
- 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.
Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.